EQ-5D Value Sets: Inventory, Comparative Review and User Guide

Rosalind Rabin, Frank de Charro, Agota Szende 1.1 Purpose of this booklet Governments and healthcare funders worldwide are making increasing use of economic evaluation to inform priority setting in health care. For various reasons, cost benefit analysis is usually rejected in favour of cost-effectiv...

Full description

Corporate Author: SpringerLink (Online service)
Other Authors: Szende, Agota (Editor), Oppe, Mark (Editor), Devlin, Nancy (Editor)
Format: eBook
Language:English
Published: Dordrecht Springer Netherlands 2007, 2007
Edition:1st ed. 2007
Series:EuroQol Group Monographs
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 02610nmm a2200313 u 4500
001 EB000358941
003 EBX01000000000000000211993
005 00000000000000.0
007 cr|||||||||||||||||||||
008 130626 ||| eng
020 |a 9781402055119 
100 1 |a Szende, Agota  |e [editor] 
245 0 0 |a EQ-5D Value Sets: Inventory, Comparative Review and User Guide  |h Elektronische Ressource  |c edited by Agota Szende, Mark Oppe, Nancy Devlin 
250 |a 1st ed. 2007 
260 |a Dordrecht  |b Springer Netherlands  |c 2007, 2007 
300 |a XI, 91 p  |b online resource 
505 0 |a Comparative review of Time Trade-Off value sets -- Comparative review of Visual Analogue Scale value sets -- Guidance to users of EQ-5D value sets 
653 |a Quality of Life Research 
653 |a Medical research 
700 1 |a Oppe, Mark  |e [editor] 
700 1 |a Devlin, Nancy  |e [editor] 
710 2 |a SpringerLink (Online service) 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
490 0 |a EuroQol Group Monographs 
856 |u https://doi.org/10.1007/1-4020-5511-0?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 306 
520 |a Rosalind Rabin, Frank de Charro, Agota Szende 1.1 Purpose of this booklet Governments and healthcare funders worldwide are making increasing use of economic evaluation to inform priority setting in health care. For various reasons, cost benefit analysis is usually rejected in favour of cost-effectiveness or cost-utility analyses, often involving the estimation of the incremental cost per Quality Adjusted Life Year (QALY) gained (Drummond et al, 2005). The estimation of QALYs gained requires valuations for all relevant health states on a scale anchored at 1 = Full health and 0 = Dead. The EQ-5D is widely used in this context and a number of value sets are available for all the health states generated by the EQ-5D descriptive system. These can be readily applied to health outcomes measured as EQ-5D profiles. EQ-5D has become one of the valuation approaches recommended by several reimbursement authorities and academic bodies in European countries (e.g. The Netherlands, Norway, Italy, Hungary, Poland, Portugal, UK), North America (e.g. Canada), and elsewhere (e.g. New Zealand). The EuroQol Group frequently receives requests for advice regarding EQ-5D valuation data. Those seeking to apply EQ-5D valuations in economic evaluation want to know about the availability of EQ-5D value sets and how they can obtain them. They also seek specific guidance about which of the available value sets they should use for their purposes